Evaluation of cervical smears at King Hussein Medical Centre, Jordan, over three and a half years

Eastern Mediterranean Health Journal

Volumn 10, Issue 4-5, 2004, Pages 676-679

  Malkawi, S R ^a   Abu Hazeem, R M ^a   Hajjat, B M ^a   Hajjiri, F K ^a  

^a KING HUSSEIN MEDICAL CENTER   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ACTINOMYCOSIS; ADULT; AGED; CANDIDA ALBICANS; CLASSIFICATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; JORDAN; MAJOR CLINICAL STUDY; MICROSCOPY; NONHUMAN; PAPANICOLAOU TEST; PATIENT REFERRAL; REVIEW; SCREENING TEST; SQUAMOUS CELL; TRICHOMONAS VAGINALIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VAGINA DISCHARGE; VAGINA FLORA; VAGINAL PRURITUS; VIRUS INFECTION;

ACTINOMYCOSIS; ADOLESCENT; ADULT; AGED; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; INCIDENCE; JORDAN; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RETROSPECTIVE STUDIES; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; SOCIAL VALUES; TRICHOMONAS VAGINITIS; UTERINE CERVICAL DISEASES; UTERINE CERVICAL DYSPLASIA; UTERINE CERVICAL NEOPLASMS; UTERINE CERVICITIS; VAGINAL SMEARS;

EID: 28444431960     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Greenlee RT et al. Cancer statistics, 2000. CA: a cancer journal for clinicians, 2000, 50(1):7-33.
2. McCrory DC et al. Evaluation of cervical cytology. Evidence report/technology assessment no.5. Rockville, Maryland, Agency for Health Care Policy and Research, 1999 (AHCPR publication no.99-E010).
3. Schwartz PE et al. Rapidly progressive cervical cancer: the Connecticut experience. American journal of obstetrics and gynecology, 1996, 175:1105-9.
4. Frame PS, Frame JS. Determinants of cancer screening frequency: the example of screening for cervical cancer. Journal of the American Board of Family Practice, 1998, 11:87-95.
5. Kenter GG et al. The cytological screening history of 469 patients with squamous cell carcinoma of the cervix uteri; does interval carcinoma exist? Acta obstetricia et gynecologica scandinavica, 1996, 75:400-3.
6. IARC Working Group on Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: duration of low risk after negative results of cervical cytology and its implications for screening policies. British medical journal, 1986, 293:659-64.
7. National Institutes of Health Consensus Development Conference statement on cervical cancer. April 1-3, 1996. Gynecologic oncology, 1997, 66:351-61.
8. Schiffman MH, Bauer HM, Hoover RN. Epidemiologic evidence that human papillomavirus infection causes most cervical intraepithelial neoplasia. Journal of the National Cancer Institute, 1993, 85:958-64.
9. Stoler MH. A brief synopsis of the role of human papillomavirus in cervical carcinogenesis. American journal of obstetrics and gynecology, 1996, 175:1091-8.
10. Richart RM et al. Human papillomavirus, IAC Task Force summary. Acta cytologica, 1998, 42:50-8.
11. Stoler MH. Human papillomavirus and cervical neoplasia: a model for carcinogenesis. International journal of gynecological pathology, 2000, 19:16-28.
12. A closer look at HPV infection. In: Tracking the hidden epidemics 2000: trends in STDs in the United States. Atlanta, Georgia, Centers for Disease Control and Prevention, 2000.
13. Johannesson G, Giersson G, Day N. The effect of mass screening in Iceland, 1965-74, on the incidence and mortality of cervical carcinoma. International journal of cancer, 1978, 21:418-25.
14. Hakama M et al. Effect of organized screening on the risk of cervical cancer in the Nordic countries. In: Miller AB et al., eds. Cancer screening. UICC project on evaluation of screening for cancer. Cambridge, United Kingdom, International Union Against Cancer, 1999:153-62.
15. Mount SL, Papillo JL. A study of 10,296 pediatric and adolescent Papanicoleau smear diagnosis in northern New England. Pediatrics, 1999, 103(3):539-45.